<?xml version='1.0' encoding='utf-8'?>
<document id="29989018"><sentence text="Effect of Korean Red Ginseng extracts on drug-drug interactions." /><sentence text="Ginseng has been the subject of many experimental and clinical studies to uncover the diverse biological activities of its constituent compounds" /><sentence text=" It is a traditional medicine that has been used for its immunostimulatory, antithrombotic, antioxidative, anti-inflammatory, and anticancer effects" /><sentence text=" Ginseng may interact with concomitant medications and alter metabolism and/or drug transport, which may alter the known efficacy and safety of a drug; thus, the role of ginseng may be controversial when taken with other medications" /><sentence text="" /><sentence text="We extensively assessed the effects of Korean Red Ginseng (KRG) in rats on the expression of enzymes responsible for drug metabolism [cytochrome p450 (CYP)] and transporters [multiple drug resistance (MDR) and organic anion transporter (OAT)] inÂ vitro and on the pharmacokinetics of two probe drugs, midazolam and fexofenadine, after a 2-wk repeated administration of KRG at different doses"><entity charOffset="300-309" id="DDI-PubMed.29989018.s6.e0" text="midazolam" /><entity charOffset="314-326" id="DDI-PubMed.29989018.s6.e1" text="fexofenadine" /><pair ddi="false" e1="DDI-PubMed.29989018.s6.e0" e2="DDI-PubMed.29989018.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29989018.s6.e0" e2="DDI-PubMed.29989018.s6.e1" /></sentence><sentence text="" /><sentence text="The results showed that 30 mg/kg KRG significantly increased the expression level of CYP3A11 protein in the liver and 100 mg/kg KRG increased both the mRNA and protein expression of OAT1 in the kidney" /><sentence text=" Additionally, KRG significantly increased the mRNA and protein expression of OAT1, OAT3, and MDR1 in the liver" /><sentence text=" Although there were no significant changes in the metabolism of midazolam to its major metabolite, 1'-hydroxymidazolam, KRG significantly decreased the systemic exposure of fexofenadine in a dose-dependent manner"><entity charOffset="65-74" id="DDI-PubMed.29989018.s10.e0" text="midazolam" /><entity charOffset="100-119" id="DDI-PubMed.29989018.s10.e1" text="1'-hydroxymidazolam" /><entity charOffset="174-186" id="DDI-PubMed.29989018.s10.e2" text="fexofenadine" /><pair ddi="false" e1="DDI-PubMed.29989018.s10.e0" e2="DDI-PubMed.29989018.s10.e0" /><pair ddi="false" e1="DDI-PubMed.29989018.s10.e0" e2="DDI-PubMed.29989018.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29989018.s10.e0" e2="DDI-PubMed.29989018.s10.e2" /><pair ddi="false" e1="DDI-PubMed.29989018.s10.e1" e2="DDI-PubMed.29989018.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29989018.s10.e1" e2="DDI-PubMed.29989018.s10.e2" /></sentence><sentence text="" /><sentence text="Because KRG is used as a health supplement, there is a risk of KRG overdose; thus, a clinical trial of high doses would be useful" /><sentence text=" The use of KRG in combination with P-glycoprotein substrate drugs should also be carefully monitored" /><sentence text="" /></document>